- Home
- AVR vs LANV Comparison
AVR vs LANV Comparison
Compare AVR & LANV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AVR
- LANV
- Stock Information
- Founded
- AVR 1999
- LANV 2015
- Country
- AVR Australia
- LANV China
- Employees
- AVR N/A
- LANV N/A
- Industry
- AVR
- LANV Blank Checks
- Sector
- AVR
- LANV Finance
- Exchange
- AVR NYSE
- LANV Nasdaq
- Market Cap
- AVR 215.6M
- LANV 219.4M
- IPO Year
- AVR 2024
- LANV N/A
- Fundamental
- Price
- AVR $5.99
- LANV $1.99
- Analyst Decision
- AVR Strong Buy
- LANV
- Analyst Count
- AVR 4
- LANV 0
- Target Price
- AVR $16.50
- LANV N/A
- AVG Volume (30 Days)
- AVR 158.4K
- LANV 66.3K
- Earning Date
- AVR 01-01-0001
- LANV 02-19-2025
- Dividend Yield
- AVR N/A
- LANV N/A
- EPS Growth
- AVR N/A
- LANV N/A
- EPS
- AVR N/A
- LANV N/A
- Revenue
- AVR $2,826,588.00
- LANV $409,961,427.00
- Revenue This Year
- AVR N/A
- LANV N/A
- Revenue Next Year
- AVR N/A
- LANV $10.45
- P/E Ratio
- AVR N/A
- LANV N/A
- Revenue Growth
- AVR N/A
- LANV N/A
- 52 Week Low
- AVR $5.10
- LANV $0.91
- 52 Week High
- AVR $6.10
- LANV $3.78
- Technical
- Relative Strength Index (RSI)
- AVR N/A
- LANV 54.35
- Support Level
- AVR N/A
- LANV $1.38
- Resistance Level
- AVR N/A
- LANV $2.04
- Average True Range (ATR)
- AVR 0.00
- LANV 0.26
- MACD
- AVR 0.00
- LANV -0.03
- Stochastic Oscillator
- AVR 0.00
- LANV 73.49
About AVR ANTERIS TECHNOLOGIES GLOBAL CORP
Anteris Technologies Global Corp. is a structural heart company committed to discovering, developing and commercializing medical devices designed to improve the quality of life for patients with aortic stenosis. Its product, the DurAVR THV system, represents a product opportunity in a new THV class of single-piece heart valves, for the treatment of aortic stenosis. Its DurAVR THV system consists of a single-piece, biomimetic valve made with its proprietary ADAPT tissue-enhancing technology and deployed with its ComASUR balloon-expandable delivery system. ADAPT is its proprietary anti-calcification tissue shaping technology that is designed to reengineer xenograft tissue into a pure, single-piece collagen bioscaffold.
About LANV Lanvin Group Holdings Limited
Lanvin Group Holdings Ltd engages in offering products ranging from apparel to leather goods, footwear, and accessories. The firm is operating mainly 5 portfolio brands, namely Lanvin, Wolford, Sergio Rossi, St. John, and Caruso. It derives the majority of its revenue from the Wolford segment.